Content about Glucagon-like peptide-1

October 14, 2011
DPP-IV inhibitors, GLP-1 analogues to see strongest growth among Type 2 diabetes drugs through 2020, study finds

Two classes of drugs for treating Type 2 diabetes will experience the biggest growth in market share of all classes of drugs for the condition, according to a new study by Decision Resources.

June 24, 2010
Metabolex, Sanofi-Aventis announce new partnership

French drug maker Sanofi-Aventis has made a deal with U.S. drug maker Metabolex to license...

March 29, 2010
Study finds Victoza more effective in treating Type 2 diabetes than competitor

A study published online in the journal Diabetes Care indicated that a once-daily diabetes drug...

February 16, 2010
Novo Nordisk announces new once-daily treatment for Type 2 diabetes

A new injectable Novo Nordisk drug for diabetes is on the shelves, the Danish drug...

© 2013 Drug Store News. All Rights Reserved.